Menu
Back to Journals » OncoTargets and Therapy » Volume 15
Silencing circZFR Inhibits the Proliferation, Migration and Invasion of Human Renal Carcinoma Cells by Regulating miR-206 [Retraction]
Received 16 May 2022
Accepted for publication 16 May 2022
Published 18 May 2022 Volume 2022:15 Pages 539—540
Wang M, Gao Y, Liu J. Onco Targets Ther. 2019;12:7537–7550.
The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. Concerns were raised regarding similarities of the western blot images within the article to those found in other articles. Further analysis found that several regions within the western blot images appeared to have been duplicated. In addition, several regions within the western blot images appeared to have been duplicated with those from other articles, which included:
- Qian et al. Salidroside alleviates high-glucose-induced injury in retinal pigment epithelial cell line ARPE-19 by down-regulation of miR-138, RNA Biology 16:10 1461–1470 2019 (https://doi.org/10.1080/15476286.2019.1637696) RETRACTED
- Zhang et al. Silencing UNC5B antisense lncRNA 1 represses growth and metastasis of human Colon cancer cells via raising miR-622, Artificial Cells, Nanomedicine, and Biotechnology 48:1 60–67 2019 (https://doi.org/10.1080/21691401.2019.1699809) RETRACTED
The authors responded to our initial queries but were unable to provide a satisfactory explanation for the similarities nor were they able to provide adequate original western blot data or verify the findings as reported. The Editor requested for the article to be retracted and the authors were notified of this.
Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.